IQVIA
IQV
$206.07
Share price
1.01%
Change (1 day)
-6.67%
Change (1 year)
Revenue for IQVIA (IQV)
Revenue in 2023 (TTM): $14.49 B
According to IQVIA's latest financial reports the company's current revenue (TTM) is $14.49 B. In 2022 the company made a revenue of $14.41 B an increase over the years 2021 revenue that were of $13.87 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for IQVIA from 2012 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $14.49 B | 0.58% |
| 2022 | $14.41 B | 3.86% |
| 2021 | $13.87 B | 22.14% |
| 2020 | $11.35 B | 2.44% |
| 2019 | $11.08 B | 6.49% |
| 2018 | $10.41 B | 6.91% |
| 2017 | $9.73 B | 41.6% |
| 2016 | $6.87 B | 19.87% |
| 2015 | $5.73 B | 5.08% |
| 2014 | $5.45 B | 7.07% |
| 2013 | $5.09 B | 4.81% |
| 2012 | $4.86 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | $0.14 B | -98.97% | 🇺🇸 USA |